InsiderTrades

Form 4 for PODD Insulet Corporation

Accepted 2023-03-14 00:00:00 ET · period of report 2023-03-13 · accession 0001127602-23-010081 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-03-14 2023-03-13 PODD Alpuche Charles Advisor S - Sale+OE $305.15 -23.4K 45.6K -34% -$7.14M
D 2023-03-14 2023-03-13 PODD Alpuche Charles Advisor M - OptEx $31.21 +23.4K 69.0K +51% +$730.3K
D 2023-03-14 2023-03-13 PODD Alpuche Charles Advisor M - OptEx $0.00 -23.4K 12.3K -65% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-03-13 S D 23,401 $305.15 45,584 D — — (F2) Footnote continued: and 5802 shares were sold in the range of $306.41 to $307.17, with a weighted average share price of $306.74. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. (F1) The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $302.98 to $307.17. Specifically: 8,975 shares were sold in the range of $302.98 to $303.98, with a weighted average share price of $303.60; 1,100 shares were sold in the range of $304.01 to $304.29, with a weighted average share price of $304.08; 7,524 shares were sold in the range of $305.35 to $306.35, with a weighted average share price of $305.94;
2 Common Common Stock 2023-03-13 M A 23,401 $31.21 68,985 D — —
3 Derivative Employee Stock Option (Right to Buy) 2023-03-13 M D 23,401 $0.00 12,347 D $31.21 · — to 2026-02-03 23,401 Common Stock (F3) This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.